 |
The Journal of Neuroscience, April 4, 2007, 27(14):3663-3676; doi:10.1523/JNEUROSCI.0448-07.2007
Previous Article | Next Article 
Cellular/Molecular
Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum
Motokazu Uchigashima,1 *
Madoka Narushima,2,3 *
Masahiro Fukaya,1
Istvan Katona,4
Masanobu Kano,2 and
Masahiko Watanabe1
1Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, Japan, 2Department of Cellular Neuroscience, Graduate School of Medical Science, Osaka University, Suita 565-0871, Japan, 3Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Tokyo 102-8666, Japan, and 4Institute of Experimental Medicine, Hungarian Academy of Sciences, Szigony utca 43, 1083 Budapest, Hungary.
Correspondence should be addressed to Masahiko Watanabe, Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, Japan. Email: watamasa{at}med.hokudai.ac.jp
Endogenous cannabinoids (endocannabinoids) mediate retrograde signals for short- and long-term suppression of transmitter release at synapses of striatal medium spiny (MS) neurons. An endocannabinoid, 2-arachidonoyl-glycerol (2-AG), is synthesized from diacylglycerol (DAG) after membrane depolarization and Gq-coupled receptor activation. To understand 2-AG-mediated retrograde signaling in the striatum, we determined precise subcellular distributions of the synthetic enzyme of 2-AG, DAG lipase- (DAGL ), and its upstream metabotropic glutamate receptor 5 (mGluR5) and muscarinic acetylcholine receptor 1 (M1). DAGL , mGluR5, and M1 were all richly distributed on the somatodendritic surface of MS neurons, but their subcellular distributions were different. Although mGluR5 and DAGL levels were highest in spines and accumulated in the perisynaptic region, M1 level was lowest in spines and was rather excluded from the mGluR5-rich perisynaptic region. These subcellular arrangements suggest that mGluR5 and M1 might differentially affect endocannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE) in MS neurons. Indeed, mGluR5 activation enhanced both DSI and DSE, whereas M1 activation enhanced DSI only. Importantly, DSI, DSE, and receptor-driven endocannabinoid-mediated suppression were all abolished by the DAG lipase inhibitor tetrahydrolipstatin, indicating 2-AG as the major endocannabinoid mediating retrograde suppression at excitatory and inhibitory synapses of MS neurons. Accordingly, CB1 cannabinoid receptor, the main target of 2-AG, was present at high levels on GABAergic axon terminals of MS neurons and parvalbumin-positive interneurons and at low levels on excitatory corticostriatal afferents. Thus, endocannabinoid signaling molecules are arranged to modulate the excitability of the MS neuron effectively depending on cortical activity and cholinergic tone as measured by mGluR5 and M1 receptors, respectively.
Key words: endocannabinoid; CB1; 2-arachidonoyl-glycerol (2-AG); diacylglycerol lipase (DAGL); mGluR5; muscarinic acetylcholine receptor M1; immunohistochemistry; striatum; mouse
Received Jan. 31, 2007;
revised Feb. 22, 2007;
accepted Feb. 23, 2007.
Correspondence should be addressed to Masahiko Watanabe, Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, Japan. Email: watamasa{at}med.hokudai.ac.jp
This article has been cited by other articles:

|
 |

|
 |
 
G. M. Drew, V. A. Mitchell, and C. W. Vaughan
Glutamate Spillover Modulates GABAergic Synaptic Transmission in the Rat Midbrain Periaqueductal Grey via Metabotropic Glutamate Receptors and Endocannabinoid Signaling
J. Neurosci.,
January 23, 2008;
28(4):
808 - 815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Adermark and D. M. Lovinger
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step
PNAS,
December 18, 2007;
104(51):
20564 - 20569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimotodani, T. Ohno-Shosaku, M. Watanabe, and M. Kano
Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release
J. Physiol.,
October 15, 2007;
584(2):
373 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohno-Shosaku, Y. Hashimotodani, M. Ano, S. Takeda, H. Tsubokawa, and M. Kano
Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons
J. Physiol.,
October 15, 2007;
584(2):
407 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-M. Jung, G. Astarita, C. Zhu, M. Wallace, K. Mackie, and D. Piomelli
A Key Role for Diacylglycerol Lipase-{alpha} in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization
Mol. Pharmacol.,
September 1, 2007;
72(3):
612 - 621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-G. Corbille, E. Valjent, G. Marsicano, C. Ledent, B. Lutz, D. Herve, and J.-A. Girault
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
J. Neurosci.,
June 27, 2007;
27(26):
6937 - 6947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Adermark and D. M. Lovinger
Combined Activation of L-Type Ca2+ Channels and Synaptic Transmission Is Sufficient to Induce Striatal Long-Term Depression
J. Neurosci.,
June 20, 2007;
27(25):
6781 - 6787.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|